Background: Few studies have examined to what extent genes might modulate the changes of systolic and diastolic blood pressure (BP) with age although, in older populations, systolic BP and diastolic BP vary with age in opposite directions. Methods: This study involved 205 men and 99 women with either systolic-diastolic or isolated systolic hypertension. Age was Ͼ50 years. Using polymerase chain reaction, four gene polymorphisms related to the reninangiotensin system were independently investigated in men and women. Adjustments to cardiovascular and renal risk factors as well to the sodium/potassium extracellular space ratio were performed. Results: Regarding the angiotensin-converting enzyme (ACE) gene polymorphism, in men Ͼ50 years of age, the slope (mm Hg per unit of age) of the age-diastolic BP (and not age-systolic BP) relationships significantly (P ϭ
T he predictive value of blood pressure (BP) as a cardiovascular (CV) risk factor is largely influenced by age. According to Framingham, 1,2 in subjects aged Ͻ50 years, diastolic BP is the stronger CV risk factor. Above this age, systolic BP, and additionally pulse pressure (PP ϭ systolic BP Ϫ diastolic BP), 3 have the predominant contribution to CV risk. These observations are influenced by the particularities of the relationships of systolic BP and diastolic BP with age. 4 At Ͻ50 years of age, both systolic BP and diastolic BP increase with age. Above this value, whereas systolic BP and PP increase continuously with age, diastolic BP tends to decrease spontaneously and independently of antihypertensive drug therapy. Epidemiologic studies have shown that, particularly at Ͼ60 years of age, CV mortality not only is positively related to the level of systolic BP but also that, at each given value of systolic BP, CV mortality is higher when diastolic BP is lower. 5, 6 Therefore, in older subjects, it is important to consider separately the increase of systolic BP and the decrease in diastolic BP with age, which may be independently responsible for CV risk and mortality.
Long-term follow-up in large populations have emphasized that not only the BP level but also the rate of change of systolic BP and diastolic BP with age contributes substantially to CV risk. 4, 7 Epidemiology indicates that there are wide intersubject variations in the slope of the curves relating systolic BP and diastolic BP to age. 4 Numerous environmental or genetic factors (or their combination) might contribute to alter the slope of such relationships.
Nevertheless, few studies examined the role of genetic factors in the mechanism of the changes of systolic BP and diastolic BP with age, although, in animals and men, the role of a hereditary predisposition has been postulated to explain the development of such mechanical factors in hypertension (for review, see References 8, 9 ). Thus, particularly in subjects Ͼ50 years of age, it is relevant to investigate separately the influence of gene polymorphisms on the changes of systolic BP and diastolic BP with age.
Recent investigations in humans have shown, that the C allele of the angiotensin II (Ang II) AT 1 receptor gene and the T allele of the endothelial nitrite oxyde synthase G 298 T gene, or even their combination, are involved in the mechanisms of the increase of systolic BP and PP with age, and therefore, in CV risk. 10 -12 However, in such studies, several questions remained unresolved. First, the results were limited to two gene polymorphisms. It is possible that other gene polymorphisms, particularly among those related to the other components of the reninangiotensin system, might be implicated. Second, due to the relatively small number of subjects, it was impossible to distinguish the different influences of gene polymorphisms in men and women. Finally, because of the wide range of age, it was not possible to investigate specifically, in older subjects, whether gene polymorphisms influenced predominantly: the increase of systolic BP with age, the decrease of diastolic BP with age, and finally, the combination of systolic BP and diastolic BP, that is PP.
The first objective of the present study was to evaluate the influence of gene polymorphisms related to the reninangiotensin system on the curve relating age to systolic BP and diastolic BP in older (Ͼ50 years) hypertensive subjects. The second objective was to investigate whether the age-diastolic BP and age-systolic BP relationships were influenced by sex. This latter objective takes into consideration at Ͼ50 years of age, that isolated systolic hypertension is a characteristic hemodynamic feature, which is mainly observed in women.
2,4,7

Methods
Study Cohort
The study was performed in patients who participated in a previously published study conducted in 13 countries. 13 Written informed consent was obtained from each patient and the protocol was approved by the Ethics Committees, in accordance with local regulations. After a 1-month washout placebo period, the patients entered a 12-month double-blind procedure. The present study was performed only in the population of patients investigated at baseline (ie, at the end of the placebo period).
Ambulatory hypertensive subjects were selected on the basis of BP measurements obtained by mercury sphygmomanometer. Systolic BP was constantly above 160 mm Hg and diastolic BP was less than or equal to or Ͼ90 mm Hg. Subjects with systolic BP Ͼ210 mm Hg and diastolic BP Ͼ110 mm Hg were excluded from the study. Patients had no clinical or biological signs of secondary hypertension, as usually defined. 13 No subjects had past symptoms of coronary artery disease, heart failure, stroke, or peripheral arterial disease. Finally, 315 men and 154 women, from 19 to 85 years old (mean 55) were investigated in this study (Table 1) . Among these patients, 73% have been previously treated for hypertension and the remaining did not receive any previous antihypertensive therapy.
All participants were examined in the morning after fasting for at least 12 h, and all underwent the same procedure. After 20 min of rest in the supine position, BP was measured on the basis of phase I and V of Korotkoff sounds using a mercury sphygmomanometer (mean of three measurements). At the end of this procedure, blood was drawn for determination of standard biochemical measurements and DNA extraction. Mean Ϯ SD (P values are adjusted to age and BMI). P (sex) ϭ GLM ANOVA test by sex; PAT ϭ prior antihypertensive treatment; BMI ϭ body mass index; Cholesterol ϭ total plasma cholesterol; Glucose ϭ plasma glucose; Potassium ϭ plasma potassium; Creatinine ϭ plasma creatinine; n ϭ absolute number of subjects; E.Sp ϭ extracellular space. Fig. 1 depicts the relationship between age and systolic BP or diastolic BP in the entire selected population. As expected from classic epidemiologic studies, 4, 7 although systolic BP increased progressively with age, diastolic BP increased with age until around age 50 years and thereafter tended to decrease markedly. The mathematical evaluation of the relationship between age and diastolic BP (Fig. 1) clearly showed that diastolic BP at 50 years of age was the critical value to divide the total population into younger (Յ50 years of age) and older (Ͼ50 years of age) subjects. Because the main goal of the present investigation was to determine, in older subjects with hypertension, the genetic factors influencing the changes of systolic BP and diastolic BP with age, the clinical and biological characteristics of the older subjects are listed in Table 2 according to sex. Note that, in this population, when women are compared with men, their tobacco consumption, plasma glucose and creatinine were lower, whereas their heart rate was higher. For comparison, the entire population is presented in Table 2 .
Genotype Investigations and Classification of Patients
The studied gene polymorphisms of interest all affected the renin-angiotensin system, and involved the angiotensin-converting enzyme (ACE D/I); the angiotensinogen (AGT) 235 M/T and 174 T/M variants; the angiotensin II type 1 receptor 1166 A/C. Standard salting-out techniques were used. The set of primers used for amplification of Abbreviations as in Table 1 .
relevant DNA regions, the probes and the methods used to detect the gene polymorphisms have been described in detail previously. 10 -12 In all cases, polymerase chain reaction amplification was used. For all probes, the washing temperature in saturated sodium citrate was adjusted according to the melting temperature of the probes. Tables 3  and 4 indicate the frequency for each genotype in each gene polymorphism. For an adequate statistical evaluation, only the ACE D/I exhibited a sufficient number of cases in each genotype, mainly in men. In this case, the traditional genotype classification (II, ID, DD) was used.
Statistical Analyses
Allele and genotype frequencies were analyzed by the gene-counting method and, in all polymorphisms, the Hardy-Weinberg equilibrium, checked by a 2 test, was considered to be maintained, as previously described. 10 -12 Other analyses were made using SAS software version 8.2 (Cary, NC) under Windows NT 2000 (Microsoft, Redmond, WA). Qualitative data were expressed as percentage of subjects in each modality and tested by a 2 test for sex comparison (Tables 1 and 2 ).
Mean's differences were tested using an analysis of variance-covariance with one factor (gender or genetic group) with the F test evaluating the model genetic groups (Tables 1, 2 , and 5). Basic adjustments were made, involving age and body mass index (BMI). Means and SEMs were derived from this analysis.
The aim of this study was to explore the age-systolic BP and age-diastolic BP relationships according to the different gene polymorphisms in subjects aged Ͼ50 years. In this observational study, only the ACE D/I gene polymorphism could be fully explored.
In a first step, we investigated the systolic BP and diastolic BP mean values in each genotype group. The P value indicates the degree of significance for means comparison between genotypes.
In a second step, we estimated the slopes of the age on systolic BP and diastolic BP relationships using a multiple linear regression procedure. This model was adjusted on CV and renal risk factors (Tables 1 and 2) , including tobacco consumption (yes or no), total plasma cholesterol and plasma glucose in (mmol/L), the plasma sodium-topotassium ratio used as an index of the sodium:potassium extracellular space, and finally, plasma creatinine (mol/ L), BMI (kg/m 2 ), and previous antihypertensive therapy (yes or no). For each genotype, the regression coefficients are presented with SE, followed by P value indicating the significance of the link between age and diastolic BP or systolic BP. The ACE D/I genotypes with the slopes of age-diastolic BP was made by a test of heterogeneity of slopes, which represents a natural extension of covariance (62) 18 (38) n (%) ϭ absolute number of subjects (% subjects). 1-1 and 2-2 represent, respectively, the wild genotype and its variants. analysis adjusted on the same covariates as for the linear regression.
Before these analyses, we verified their necessary conditions. We used Levene's test of equality of variance within the different strata determined by the six groups composed by gender and genotypes for diastolic BP and ACE D/I. Finally, four tests were made on diastolic BP (three according to each the three genotypes, and one according the ACE alleles). For this reason, we applied the Bonferroni alpha risk adjustment (dividing 0.05 by 4); therefore, only results with a P value Ͻ .0125 were considered significant.
Results
Study of Mean Values
In Table 5 the adjusted mean values of systolic BP and diastolic BP are presented for each gene polymorphism according to each genotype. No gene effect was observed. In this Table, only results in men Ͼ50 years of age are presented, but negative results were also observed in women.
Slope of the Age-Diastolic BP and Age-Systolic BP Relationships
Significant results were observed only in men and only for the ACE D/I gene polymorphism. Furthermore, these results were observed only for the age-diastolic BP and not for the age-systolic BP relationship. The slope (mm Hg per unit age) of the age-diastolic BP curves was significantly steeper (P [slope comparison] ϭ .0092) for the DD genotype (Ϫ0.79 Ϯ 0.15; P [age/diastolic BP link] Ͻ .0001) than for the ID (Ϫ0.53 Ϯ 1.10; P [age/diastolic BP link] Ͻ .0001) and II (Ϫ0.23 Ϯ 0.11; P [age/diastolic BP link] ϭ .0789) genotypes. Note that all the slopes were negative and that, for each given genotype, these slopes were constantly steeper in men than in women (data not shown). No significant interslope difference was observed between genotypes in women. Fig. 2 depicts the age-diastolic BP relationship according to each genotype in men Ͼ50 years of age. Note that at Ͼ60 years of age, diastolic BP was lower in the population with DD than with II or ID genotypes. Adjustment to the sodium-to-potassium ratio, used as an index of sodium-to-potassium extracellular space, did not modify the results.
Discussion
This study examined the age-systolic BP and age-diastolic BP relationships in an older (Ͼ50 years) population of hypertensive subjects with either systolic-diastolic hypertension or isolated systolic hypertension. The slope of the age-diastolic BP (and not systolic BP) relationship was significantly steeper in the DD than in ID and II genotypes in a single case of gene polymorphism related to the renin-angiotensin system: the ACE D/I gene polymorphism. The finding was observed only in men. No comparable results were observed for other gene polymorphisms as those related to angiotensin II AT 1 receptor or angiotensinogen. These data were obtained using a crosssectional analysis. We and other investigators 4, 14 have shown that an adequate concordance may be observed between cross-sectional and longitudinal investigations relating age to systolic BP or diastolic BP.
In many reports on the genetics of hypertension, the hypothesis that genetic variability could lead to hypertension has been tested on the basis of comparison of mean values of diastolic BP in patients with different genotypes (see Review 9 ). In these reports, the classification of hypertension was based on a single point of the BP curve, diastolic BP, and never involved systolic BP or PP. In the present study, as in many other reports in the literature, 9 negative results were observed using this methodology. In the present investigation, the principal goal was to test the hypothesis that genes might modulate the influence of age on systolic BP and diastolic BP, and therefore might play a role in CV risk through an alteration of the age-related change of these mechanical factors. Because, in older populations, the changes of systolic BP and diastolic BP with age differ markedly ( Fig. 1) , it is important to determine whether the present results are influenced by some statistical artifact reflecting the well-established correlations between systolic BP and diastolic BP. 3, 4 In this study, such an issue raised minor concern because the modulating influence of the studied gene polymorphism was observed predominantly for diastolic BP and never for systolic BP. This finding does not exclude that other gene polymorphisms might influence predominantly the agerelated changes in systolic BP. In older subjects, systolic BP may be influenced by gene polymorphisms related not only to the renin-angiotensin system, but also to other vasoactive substances and to alterations of the vessel wall extracellular matrix. 15, 16 The slope of the curve relating diastolic BP to age was shown to represent a very interesting phenotype. First, the slope was negative in subjects Ͼ50 years of age and was also largely influenced by sex (Fig. 1) . For a given genotype, the slope was usually steeper in men than in women.
Because the finding was mainly observed at ages Ͼ50 years, a possible interaction between age-related changes of diastolic BP and sex hormones or their genotype may be expected to occur. 10 -12 Second, the genotype itself influenced in men the slope of age-diastolic BP relationship, which was steeper with the DD than with the ID or II genotypes.
O'Donnel et al 17 from the Framingham heart Study found evidence for association and genetic linkage of the ACE gene with hypertension and BP in men, but not in women. Fornage et al 18 showed that variations in a microsatellite marker, which is very close to the ACE gene locus, influenced interindividual BP differences in young white men, but not in women. The present study confirms the sex influence observed for the ACE gene polymorphism and suggests for the first time that, in hypertensive subjects Ͼ50 years of age, the presence of the D allele influences the physiologic reduction of diastolic BP with age. The ACE plasma levels are known to be increased with the number of D alleles 19 and might be responsible not only for an enhanced production of angiotensin II, a potent vasoconstrictor and stimulator of vascular growth, but also for a concomitant inactivation of bradykinin resulting in decreased tissue perfusion. 19, 20 All these possible effects may vary with age and contribute to the observed results. The recent observation of significant associations between the ACE gene polymorphism and systolic hypertension in the elderly, 21 and the availability of ACE inhibitors in subjects with hypertension 13 agree with the present interpretation.
In conclusion, this study has shown that the ACE gene polymorphism influences the relationship between age and diastolic BP. This finding, which is age and sex dependent, affects principally the steepness of the age-diastolic BP curve in hypertensive men Ͼ50 years of age, and therefore, might play a role in the mechanism of CV risk in these patients. Longitudinal studies are required to evaluate this interesting problem.
